The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.31

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Females, 2007-2013

Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 79,125 70.9 70.5 71.3 90.6 89.5 91.6 80.2 79.7 80.7 60.5 59.8 61.2
1 Hodgkin Lymphoma 6,722 87.4 86.4 88.4 97.0 95.4 98.0 91.5 90.5 92.4 56.8 52.4 61.0
2 Non-Hodgkin lymphoma 70,440 69.8 69.3 70.2 88.7 87.3 89.9 78.5 78.0 79.1 61.2 60.5 61.9
2(a) Non-Hodgkin lymphoma, B-cell 65,588 70.0 69.5 70.5 89.2 87.8 90.5 79.0 78.4 79.6 61.7 60.9 62.4
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 3,729 68.9 67.2 70.6 89.1 87.5 90.5 40.3 36.8 43.9 18.6 13.8 23.9
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 58,365 70.2 69.6 70.7 89.8 85.9 92.7 80.6 80.0 81.2 62.1 61.3 62.9
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 12,321 80.5 79.3 81.7 - - - 88.9 87.5 90.1 75.9 74.2 77.6
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 11,170 82.7 81.5 83.9 - - - 91.1 89.7 92.3 78.1 76.3 79.8
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 27 47.0 24.9 66.4 - - - - - - - - -
2(a) 2.1.3. Mantle-cell lymphoma 1,124 59.3 55.2 63.2 - - - 68.9 62.9 74.2 53.6 47.9 58.9
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,213 82.9 79.0 86.1 - - - 90.1 85.8 93.2 78.5 72.9 83.1
2(a) 2.2.1. Lymphoplasmacytic lymphoma 582 77.3 71.5 82.0 - - - 86.0 78.7 90.9 72.0 63.8 78.7
2(a) 2.2.2. Waldenstrom macroglubulinemia 631 87.6 82.2 91.5 - - - 93.3 87.6 96.5 83.8 75.6 89.5
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 15,405 62.3 61.3 63.3 87.2 81.2 91.4 75.1 73.8 76.3 52.3 50.8 53.7
2(a) 2.3.1. DLBCL, NOSc 15,151 61.9 60.9 62.9 88.1 82.0 92.3 74.6 73.3 75.9 52.3 50.8 53.7
2(a) 2.3.2. Intravascular large B-cell lymphoma 33 61.3 40.2 76.9 - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma - - - - - - - - - - - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 217 89.3 83.6 93.2 - - - 91.3 85.6 94.9 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 637 57.6 53.2 61.8 91.2 84.2 95.2 56.8 50.8 62.4 35.5 27.8 43.2
2(a) 2.5. Marginal-zone lymphoma (MZL) 5,157 90.7 89.1 92.1 - - - 94.7 93.1 95.9 87.3 84.5 89.6
2(a) 2.5.1. Splenic MZL 455 82.7 76.0 87.7 - - - 87.0 78.6 92.3 79.2 68.5 86.6
2(a) 2.5.2. Extranodal MZL, MALTc type 3,212 94.9 92.9 96.3 - - - 96.8 95.1 97.9 92.8 88.8 95.4
2(a) 2.5.3. Nodal MZL 1,490 84.2 80.9 86.9 - - - 91.4 87.6 94.1 78.8 73.7 83.0
2(a) 2.6. Follicular lymphoma 8,993 88.3 87.2 89.4 - - - 93.8 92.8 94.7 81.8 79.6 83.7
2(a) 2.7. Hairy-cell leukemia 310 90.5 82.9 94.8 - - - 97.3 92.4 99.0 75.8 57.9 86.9
2(a) 2.8. Plasma cell neoplasms 14,319 49.4 48.3 50.5 - - - 63.5 61.9 65.1 39.6 38.0 41.1
2(a) 2.8.1. Plasmacytoma 755 67.6 62.8 72.0 - - - 80.3 74.3 85.1 52.9 45.5 59.8
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 13,564 48.4 47.2 49.5 - - - 62.4 60.7 64.0 38.9 37.4 40.4
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 3,494 68.5 66.2 70.7 - - - 80.0 77.0 82.7 62.4 59.2 65.4
2(b) Non-Hodgkin lymphoma, T-cell 4,348 67.0 65.2 68.7 85.2 80.7 88.7 73.8 71.7 75.8 52.0 48.6 55.2
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 122 68.4 59.0 76.1 92.4 80.9 97.1 56.3 41.9 68.4 - - -
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 4,208 67.1 65.2 68.8 83.8 78.5 87.9 74.5 72.3 76.4 52.4 49.0 55.7
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,133 92.6 89.6 94.8 93.2 59.7 99.0 95.3 92.2 97.2 87.6 79.8 92.5
2(b) 2.1.1. Mycosis fungoides 1,103 93.9 90.8 96.0 93.2 59.7 99.0 96.1 93.0 97.8 89.7 81.4 94.4
2(b) 2.1.2. Sezary syndrome 30 42.4 21.4 62.0 - - - - - - - - -
2(b) 2.2. Peripheral T-cell lymphoma 2,363 59.4 57.0 61.7 84.2 74.4 90.5 70.7 67.7 73.5 42.3 38.3 46.4
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 798 37.7 33.6 41.9 - - - 50.2 44.3 55.8 24.8 19.1 30.9
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 338 45.9 39.5 52.1 - - - 63.6 54.0 71.7 33.9 25.7 42.2
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 44 90.5 73.5 96.8 - - - 85.0 63.1 94.4 - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 436 65.5 60.1 70.4 84.0 70.0 91.8 73.8 67.3 79.3 33.1 22.5 44.2
2(b) 2.2.5. Hepatosplenic T-cell lymphoma - - - - - - - - - - - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 32 7.7 0.7 26.3 - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 477 85.2 80.1 89.1 - - - 89.9 84.6 93.5 77.2 66.5 84.9
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 223 90.8 82.3 95.4 - - - 95.2 88.1 98.1 79.4 56.4 91.2
2(b) 2.3. Adult T-cell leukemia/lymphoma 429 56.0 50.0 61.6 82.1 74.6 87.5 40.6 30.4 50.5 23.9 12.9 36.7
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 162 44.5 34.8 53.7 - - - 48.8 38.6 58.3 37.1 18.8 55.5
2(b) 2.5. T-cell large granular lymphocytic leukemia 47 74.8 56.1 86.4 - - - 80.1 58.5 91.3 - - -
2(b) 2.6. Prolymphocytic leukemia, T-cell 74 13.3 4.5 26.9 - - - 22.1 8.8 39.2 7.0 0.5 26.4
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell - - - - - - - - - - - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 504 64.3 59.2 68.9 89.8 82.3 94.3 66.8 57.8 74.4 49.0 41.5 56.2
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 196 69.6 62.3 75.8 90.6 83.2 94.9 53.7 38.0 67.1 19.3 7.8 34.7
2(c) 2. Prolymphocytic leukemia, unknown lineage - - - - - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 288 61.2 54.2 67.4 - - - 73.9 62.3 82.4 54.1 45.3 62.0
2(*) 1. Total precursor lymphoma/leukemiad 4,047 69.0 67.4 70.6 89.3 87.8 90.6 42.0 38.6 45.2 18.7 14.3 23.6
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 63 62.1 44.7 75.4 - - - 82.0 58.0 93.0 - - -
4 Lymphoid neoplasm, NOSc 1,900 51.9 49.0 54.8 86.4 66.7 94.8 70.5 66.2 74.3 41.4 37.6 45.1

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.